商铺首页
公司详情
产品陈列室
公司动态
联系方式
基本信息
企业名称
精化快车
企业地址
上海市上海市上海市浦东新区盛夏路570号706室
成立日期
2007
企业规模(人)
50至59
年销售额(USD)
500,000至999,999
企业简介
遐瑞集团成立于2007年,总部位于上海,业务涉及原料药,医药中间体,农化产品,精细化学品的开发、生产和销售。通过凝聚人才、技术和潜能,我们努力为实现更美好的生活做出贡献。 公司在上海拥有1100平米研发中心,包括2个公斤级实验室,反应器体积从10升至100升,可同时进行多个项目的中试放大研究。我们的科研管理团队均由经验丰富的博士组成,并拥有国际先进的分析检测仪器以及高速、便捷的文献数据库接入。 公司两个cGMP生产基地位于浙江和江苏,总面积约53300平米,以专业开发生产抗病毒,抗癌,心血管等原料药和高级中间体为主。
主要竞争优势
品牌,国际认证/标准,经验丰富的研发人员,发货速度,生产能力,产品线丰富,合同定制,接受买家的规格要求,接受小额订单,良好的信誉,优质服务
邮政编码
201203
其他竞争优势
Specifications This product is currently in stcok. Purity > 99%. About us 1. Found in 2005, headquartered in Shanghai. 2. Owns subsidiaries in Shanghai, Hebei and Shandong. 3. Scope of business Pharmaceutical intermediates, insect pheromones, fine chemicals mass production, Custom synthesis and manufacturing. 4. Chemical process development and optimization. 5. Development , promotion and marketing of advanced chemical technology Why choose us 1. In-depth process knowledge and “know-how”, excellent project management skills. 2. Innovation-driven process research, development and production capability (fine chemicals, pharmaceutical ntermediates, GLP / GMP production etc.). 3. Extensive international cooperation experience. 4. Flexible business collaboration models. 5. Outstanding communication skills. 6. Well established IP protection system. 7. providing payment terms according to customers’ needs, ranging from net 30 to 240 days QA/QC 1. The purity of our chemicals are typically >98% , The structures are confirmed by NMR, LC-MS and other analytical methods 2. Intermediates and final products are analyzed by GC, HPLC, IR, NMR, MS, elemental analysis, atom-absorpting analysis and crystallographical methods.
贸易信息
业务类型
制造商,贸易公司,服务商
主要销售市场
北美洲,中/南美洲,西欧,东欧,大洋洲,亚洲,中东,非洲
主营产品类别
精细化工,合同外包、定制服务及咨询,天然提取物,中间体,原料药
合同定制与外包服务
CRO,CMO
参展信息
主营产品
all-trans-Retinol(68-26-8);ALL-TRANS-RETINAL(116-31-4);Mafenide hydrochloride(138-37-4);L-(+)-Ergothioneine(497-30-3);Polyquaternium-51(125275-25-4 );Bis(2,2,6,6-tetramethyl-1-piperidinyloxy-4-yl) sebacate(2516-92-9);P-XYLYLENEDIPHOSPHONIC ACID TETRAETHYL ESTER(*4546-04-7);Bis(vinyl sulfone) methane(3278-22-6);Ethyl 3,4-dihydroxybenzoate(3943-89-3);Disodium 4-dodecyl-2,4'-oxydibenzenesulfonate(7575-62-4);VEEA(86273-46-3);Benzenesulfonamide, N-(4-hydroxyphenyl)-(5471-90-9);4-Mercaptomethyl-3,6-dithia-1,8-octanedithiol(131538-00-6);N,N'-di-tert-butylethylenediamine(4062-60-6);N,N-Dimethyl-butylamine(927-62-8);(1S-4R)-4-[[(1,1-diMethylethoxy)carbonyl]aMino]- 2-Cyclopentene-1-carboxylic acid Methyl ester(229613-93-8);1-BROMO-2-BUTYNE(3355-28-0);4-Hydroxy-2-butanone(590-90-9);5-AMINO-3-METHYL-1,2,4-THIADIAZOLE(17467-35-5);N-Boc-4-oxo-L-proline(84348-37-8);(S)-4-Oxopyrrolidine-2-carboxylic acid hydrochloride(54615-47-3);[2-[2-(Fmoc-amino)ethoxy]ethoxy]acetic acid(166108-71-0);2-Pyridinol-1-oxide(13161-30-3);PTZ-343(101199-38-6);3-OXETANECARBOXYLIC ACID, 3-METHYL(28562-68-7);3-dioxolane-4-methanol(14347-78-5);Trifluoromethanesulfonic acid tert-butyldimethylsilyl ester(69739-34-0);Polymyxin B sulfate(1405-20-5);Bimatoprost(155206-00-1);Prostaglandin E1(745-65-3);Milrinone(78415-72-2);Alpha-GPC(28319-77-9);PHOSPHOLIPON(97281-48-6);Vardenafil HCl Trihydrate (224785-90-4);2,6-Dichloroaniline(608-31-1);2,4,6-Trimethylaniline(*88-05-1);4-Amino-2,6-dichlorophenol(5930-28-9);Cyclopentanone(120-92-3);Neophyl chloride(515-40-2);Butylphenylacetonitrile(3288-99-1);Nonafluorobutanesulfonyl fluoride(375-72-4);Potassium nonafluoro-1-butanesulfonate(29420-49-3);Trifluoromethanesulfonic acid(1493-13-6);Trimethylsilyl trifluoromethanesulfonate(27607-77-8);Trifluoromethanesulfonic anhydride(358-23-6);Lithium trifluoromethanesulfonate(33454-82-9);Bis(trifluoromethane sulfonimide)(82113-65-3);PotassiuM bis(trifluoroMethylsulfonyl)iMide(90076-67-8);Trifluoromethyl trifluoromethanesulfonate(3582-05-6);2,2,2-Trifluoroethyl trifluoromethanesulfonate(6226-25-1);Zinc trifluoromethanesulphonate(54010-75-2);Methyl trifluoromethanesulfonate(333-27-7);Barium trifluoromethanesulfonate(2794-60-7);FC-4400(405514-94-5);3,5-Dichloro-4-(1,1,2,2-tetrafluoroethoxy)aniline(104147-32-2);1,1,2,2-Tetrafluoroethyl methyl ether(425-88-7);1,1,2,2-Tetrafluoroethyl 2,2,2-trifluoroethyl ether(406-78-0);Ethyl 1,1,2,2-tetrafluoroethyl ether(512-51-6);1,1,2,2-Tetrafluoroethyl-2,2,3,3-tetrafluoropropylether(16627-68-2);1H,1H,5H-Perfluoropentyl-1,1,2,2-tetrafluoroethylether(16627-71-7);Ethylene glycol bis(1,1,2,2-tetrafluoroethyl) ether(358-39-4);Chlorodimethylsilane(1066-35-9);Methylphenyldiethoxysilane(775-56-4);DIPHENYLMETHYLETHOXYSILANE(1825-59-8);Tetramethylsilane(75-76-3);1H,1H,2H,2H-PERFLUOROOCTYLTRIETHOXYSILANE(51851-37-7);tert-Butylchlorodiphenylsilane(58479-61-1);Chloroiridic acid(110802-84-1);Palladium (II) Acetate(3375-31-3);Palladium chloride(*7647-10-1);Chloroiridic acid(110802-84-1);Tetrakis(triphenylphosphine)palladium(14221-01-3);Cobalt carbonyl(10210-68-1);1,2- Bis(diphenylphosphino)ethane]dichloropalladi um(II)(19978-61-1);[1,3-Bis(diphenylphosphino)propane]palladium(II) chloride(59831-02-6);Dichloro[9,9-dimethyl-4,5-bis(diphenylphosphino)xanthene]palladium(II)(205319-10-4);Dichloro[bis(diphenylphosphinophenyl)ether]palladium(II)(205319-06-8);binap pdcl2(210693-55-3);Bis{bis(tert-butyl)[4-(dimethylamino)phenyl]phosphine}palladium(II) chloride(887919-35-9);Dichlorobis(di-tert-butylphenylphosphine)palladium(II(34409-44-4);Dichlorobis(pyridine)palladium(II)(14872-20-9);(Acetylacetonato)dicarbonylrhodium(I)(14874-82-9);Carbonyl(acetylacetonato)(triphenylphosphine)rhodium(I)(25470-96-6);Tris(triphenylphosphine)chlororhodiuM(14694-95-2);Rhodium(III)acetylacetonate(14284-92-5);Carbonyltris(triphenylphosphine)rhodium(I)hydride(17185-29-4);Bis(triphenylphosphine)rhodium(I) carbonyl chloride(13938-94-8);Dichlorotetrakis(2-(2-pyridinyl)phenyl)diiridium(III)(92220-65-0);Acetylacetonatobis(2-phenylpyridine)iridium(337526-85-9);Tris(2-phenylpyridine)iridium(III)(94928-86-6);Bis(1-phenyl-isoquinoline-C2,N)(acetylacetonato)iridium(III)(435294-03-4);Tris[1-phenylisoquinoline-C2,N]iridium(III)(435293-93-9);(1,5-Cyclooctadiene)(hexafluoroacetylacetonato)iridium(I)(34801-95-1);Sodium arsenite(7784-46-5);Arsenic acid(7778-39-4);Potassium dihydrogenarsenate(7784-41-0);Arsenic(7440-38-2);Arsenic trioxide(1327-53-3);Zinc arsenide(12006-40-5);4-Aminobenzonitrile(873-74-5);p-Tolunitrile(104-85-8);m-Tolunitrile(620-22-4);2-(3'-Chloro[1,1'-biphenyl]-4-yl)-4,6-diphenyl-1,3,5-triazine(1443049-84-0);2-Bromoanthracene(7321-27-9);3'-bromo-3-iodo-1,1'-biphenyl(187275-76-9);11-(biphenyl-3-yl)-11,12-dihydroindolo[2,3-a]carbazole(1449754-80-6);11-[1,1'-biphenyl]-4-yl-11,12-dihydroindolo[2,3-a]carbazole(2095887-12-8);1,3-Pyrenediamine, 7-(1,1-dimethylethyl)-N1,N1,N3,N3-tetrakis[4-(1,1-dimethylethyl)phenyl]-(2114981-63-2);4-Chloro-3,5-dimethylphenol(88-04-0);β-Alanine(107-95-9);(S)-3-aminobutanoic acid(3775-73-3);(E,E,E)-2,7-dimethylocta-2,4,6-trienedial(5056-17-7);1-(4'-bromo-[1,1'-biphenyl]-4-yl)adamantane(204777-99-1);1-ALLYL-3-(2-HYDROXYETHYL)-2-THIOUREA(105-81-7);N3-PEG4-NH2(951671-92-4);Hexaethylene glycol(2615-15-8);1-Dodecanethiol(112-55-0)
参展展会
第二十三届世界制药原料中国展
展会时间
2025-03-06至2025-07-31
展位号
E2D51
展品分类
Active Pharmaceutical Ingredients;Intermediates & Fine Chemicals;Natural Extracts;CMO & CRO;Veterinary Drug & Feed Additives
参展信息
×